Cryptic exposure to arsenic

Indian Journal of Dermatology, Venereology and Leprology

Volumn 71, Issue 4, 2005, Pages 230-235

  Rossy, Kathleen M ^a   Janusz, Christopher A ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Arsenic; Arsenicism; Bladder cancer; Carcinogenesis; Environmental toxins; Lung cancer; Skin cancer

Indexed keywords

ANTIASTHMATIC AGENT; ARSENIC DERIVATIVE; ARSENIC SULFIDE; ARSENIC TRIOXIDE; ARSENOUS IODIDE; CHELATING AGENT; DIMERCAPROL; HERBACEOUS AGENT; MERCURIC IODIDE; MERCURY DERIVATIVE; MINERAL; OPIATE; RETINOID; SUCCIMER; UNCLASSIFIED DRUG; UNITHIOL; VITAMIN;

ARSENIC POISONING; CLINICAL FEATURE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; KERATOSIS; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; SKIN; VISCERA; WATER CONTAMINATION;

EID: 23944496953     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.16612     Document Type: Review

References (55)

1. Brown KG, Ross GL. American Council on Science and Health. Arsenic, drinking water, and health: a position paper of the American Council on Science and Health. Regulatory Toxicology Pharmacology 2002;36:162-74.
2. Neubauer O. Arsenical cancer: A review. Br J Cancer 1947;1:192-251.
3. Carlson-Lynch H, Beck BD, Boardman PD. Arsenic risk assessment. Environ Health Perspect 1995;102:354-6.
4. Fishbein L. Sources, transport and alterations of metal compounds: an overview. 1. Arsenic, beryllium, cadmium, chromium, and nickel. Environ Health Perspect 1981;40:43-64.
5. Jackson R, Grainge JW. Arsenic and cancer. Canad Med Assoc J 1975;113:396-401.
6. Bennett BG. Exposure of man to environmental arsenic- an exposure commitment assessment. Sci Total Environ 1981;20:99-107.
7. Spallholz JE, Mallory Boylan L, Rhaman MM. Environmental hypothesis: is poor dietary selenium intake an underlying factor for arsenicosis and cancer in Bangladesh and West Bengal, India? Sci Total Environ 2004;323:21-32.
8. Joshi H, Ghosh AK, Singhal DC, Kumar S. Arsenic contamination in parts of Yamuna sub-basin, West Bengal. Indian J Environ Health 2003;45:265-74.
9. Hall AH. Chronic arsenic poisoning. Toxicology Letters 2002;128:69-72.
10. Mahata J, Chaki M, Ghosh P, Das LK, Baidya K, Ray K, et al. Chromosomal aberrations in arsenic-exposed human populations: a review with special reference to a comprehensive study in West Bengal, India. Cytogenetic Genome Research 2004;104:359-64.
11. Samanta G, Sharma R, Roychowdhury T, Chakraborti D. Arsenic and other elements in hair, nails, and skin-scales of arsenic victims in West Bengal, India. Sci Total Environ 2004;326:33-47.
12. Roychowdhury T, Tokunaga H, Ando M. Survey of arsenic and other heavy metals in food composites and drinking water and estimation of dietary intake by the villagers from an arsenic affected area of West Bengal, India. Sci Total Environ 2003;308:15-35.
13. Sommers SC, McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer 1953;6:347-59.
14. Voron DA, Tonkens SW. Arsenical keratoses. Cutis 1975;15:703-7.
15. Schroeder HA, Balassa JJ. Abnormal trace metals in man: arsenic. J Chronic Dis 1966;19:85-106.
16. Blejer HP, Wagner W. Inorganic arsenic - ambient level approach to the control of occupational carcinogenic exposures. Ann New York Acad Sci 1976;271:179-86.
17. Schwartz RA. Arsenic and the skin. Intern J Dermatol 1997;36:241-50.
18. Southwick GJ, Schwartz RA. Arsenically-associated cutaneous squamous cell carcinoma with hypercalcemia. J Surg Oncol 1979;12:115-8.
19. Chakraborti D, Mukherjee SC, Pati S, Sengupta MK, Rahman MM, Chowdhury UK, et al. Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger? Environ Health Perspect 2004;111:1194-201.
20. Rahman MM, Mandal BK, Chowdhury TR, Sengupta MK, Chowdhury UK, Lodh D, et al. Arsenic groundwater contamination and sufferings of people in North 24-Parganas, one of the nine arsenic affected districts of West Bengal, India. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003;38:25-59.
21. Roychowdhury T, Uchino T, Tokunaga H, Ando M. Arsenic and other heavy metals in soils from an arsenic-affected area of West Bengal, India. Chemosphere 2002;49:605-18.
22. Allred M, Campolucci S, Falk H, Ganguly NK, Saiyed HN, Shah B. Bilateral environmental and occupational health program with India. Int J Environ Health 2003;206:323-32.
23. Al Rmalli SW, Haris PI, Harrington CF, Ayub M. A survey of arsenic in foodstuffs on sale in the United Kingdom and imported from Bangladesh. Sci Total Environ 2005;337:23-30.
24. Abedin MJ, Cresser MS, Meharg AA, Feldmann J, Cotter-Howells J. Arsenic accumulation and metabolism in rice. Environ Sci Technol 2002;36:962-8.
25. Hughes GS Jr, Davis L. Variegate porphyria and heavy metal poisoning from ingestion of "moonshine." South Med J 1983;76:1027-9.
26. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease: an ecological study in Finland. Am J Public Health 1994;84:1223-8.
27. Evens AM, Tallman MS, Gartenhaus RB. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leukemia Research 2004;28:891-900.
28. Barbery JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol 2003;21:3609-15.
29. Tay CH, Seah CS. Arsenic poisoning from anti-asthmatic herbal preparations. Med J Austral 1975;2:424-8.
30. Datta DV. Arsenic in opium. Lancet 1977;1:484.
31. Narang AP, Chawla LS, Khurana SB. Levels of arsenic in Indian opium eaters. Drug Alcohol Depend 1987;20:149-53.
32. Werner MA, Knobeloch LM, Erbach T, Anderson HA. Use of imported folk remedies and medications in the Wisconsin Hmong community. WMJ 2001;100:32-4.
33. Peters HA, Croft WA, Woolson EA. Seasonal arsenic exposure from burning chromium-copper-arsenate-treated wood. JAMA 1984;25l:2393-6.
34. Ursitti F, Vanderlinden L, Watson R, Campbell M. Assessing and managing exposure from arsenic in CCA-treated wood play structures. Can J Public Health 2004;95:429-33.
35. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K, et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16:82-6.
36. Clausen C. Improving the two-step remediation process for CCA-treated wood: Part I. Evaluating oxalic acid extraction. Waste Management 2004;24:401-5.
37. Clausen C. Improving the two-step remediation process for CCA-treated wood: Part II. Evaluating bacterial nutrient sources. Waste Management 2004;24:407-11.
38. Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, et al. Blackfoot Disease Study Group. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 2004;292:2984-90.
39. Stephenson D, Spear T, Seymour M, Cashell L. Airborne exposure to heavy metals and total particulate during abrasive blasting using copper slag abrasive. Appl Occup Environ Hyg 2002;17:437-43.
40. Park MJ, Currier M. Arsenic exposure in Mississippi: a review of cases. South Med J 1991;84:461-4.
41. Grobe JW. Periphere Durchblutungssförungen und Akrocyanose bei arsengeschädigten Moselwinzern. Berufs Dermatosen 1976;24:78-84.
42. Edelman P. Environmental and workplace contamination in the semiconductor industry: implications for future health of the workforce and community. Environ Health Perspect 1990;86:291-5.
43. Liao YH, Yu HS, Ho CK, Wu MT, Yang CY, Chen JR, et al. Biological monitoring of exposure to aluminum, gallium, indium, arsenic, and antimony in optoelectronic industry workers. J Occup Environ Med 2004;46:931-6.
44. Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol Appl Pharmacol 2003;193:309-34.
45. Kinoshita H, Hirose Y, Tanaka T, Yamazaki Y. Oral arsenic trioxide poisoning and secondary hazard from gastric content. Ann Emerg Med 2004;44:625-7.
46. Schoolmaster WL, White DR. Arsenic poisoning. South Med J 1980;73:198-208.
47. Madorsky DD. Arsenic in dermatology. J Assoc Milit Dermatol 1977;3:19-22.
48. Centeno JA, Mullick FG, Martinez L, Page NP, Gibb H, Longfellow D, et al. Pathology related to chronic arsenic exposure. Environ Health Perspect 2002;110:883-6.
49. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. Arsenic concentrations in well water and the risk of bladder and kidney cancer in Finland. Environ Health Perspect 1999;107:705-10.
50. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven year follow up study in Taiwan. Cancer Res 1995;55:1296-300.
51. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992;66:888-92.
52. Heyman A, Pfeiffer JB Jr, Willett RW, Taylor HM. Peripheral neuropathy caused by arsenical intoxication. A study of 41 cases with observations on the effects of BAL (2,3, dimercapto-propanol). New Engl J Med 1956;254:401-9.
53. Thianprasit M. Chronic cutaneous arsenicism treated with aromatic retinoid. J Med Assoc Thailand 1984;67:93-100.
54. Rogozinski T, Geiger JM, Czarnetzki BM, Jablonska S. Acitretin in the treatment and prevention of viral, premalignant and malignant skin lesions. J Dermatol Treat 1989;1:91-3.
55. Schwartz RA. Skin Cancer Recognition and Management. New York: Springer-Verlag; 1988. p. 11-24.